Bayer AG, a global leader in the life sciences sector, is headquartered in Leverkusen, Germany. Founded in 1863, Bayer has established itself as a prominent player in the pharmaceutical, consumer health, and agricultural industries. The company operates extensively across Europe, North America, and Asia, providing innovative solutions that enhance health and nutrition. Bayer's core offerings include prescription medications, over-the-counter products, and crop science solutions, distinguished by their commitment to research and development. Notable achievements include the development of groundbreaking treatments and sustainable agricultural practices, positioning Bayer as a trusted name in health and agriculture. With a strong market presence and a dedication to improving lives, Bayer continues to drive advancements that benefit society globally.
How does Bayer's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Bayer's score of 74 is higher than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Bayer reported total greenhouse gas emissions of approximately 11,340,000,000 kg CO2e, with Scope 1 emissions at about 1,880,000,000 kg CO2e, Scope 2 emissions at approximately 1,080,000,000 kg CO2e (market-based), and Scope 3 emissions reaching about 7,700,000,000 kg CO2e. The combined Scope 1 and 2 emissions totalled around 2,960,000,000 kg CO2e. Bayer has set ambitious climate commitments, aiming for net-zero emissions across all scopes (1, 2, and 3) by 2050. In the near term, the company targets a 42% reduction in absolute Scope 1 and 2 emissions by 2029, using 2019 as the baseline. Additionally, Bayer aims to reduce Scope 3 emissions by 12% within the same timeframe. These targets are aligned with the Science Based Targets initiative (SBTi) and reflect Bayer's commitment to sustainable practices in the pharmaceutical and biotechnology sector. Bayer's initiatives include implementing energy efficiency measures and transitioning to 100% renewable electricity at its sites. The company also aims to enable its farming customers to reduce their greenhouse gas emissions per kilogram of crop produced by 30% by 2030. Overall, Bayer's comprehensive approach to reducing carbon emissions demonstrates its commitment to addressing climate change and promoting sustainability within its operations and supply chain.
Access structured emissions data, company-specific emission factors, and source documents
| 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 2 | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 3 | 1,215 | 0,000 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Bayer's Scope 3 emissions, which decreased by 16% last year and increased significantly since 2004, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 72% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 76% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Bayer has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Common questions about Bayer's sustainability data and climate commitments